Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc
Bullboard Posts
User Avatar Image
(38)
•••
Comment by Hideawayon Jun 18, 2019 12:30pm
137 Views
Post# 29836275

RE:I know it’s low volume manipulation but...

RE:I know it’s low volume manipulation but...It's beyond frustrating. We need some news to stop the day traders, if not, where is the botton?
Too bad they could not announce some positive advancements with other partners like CIIE, Zoetis or Leidos. 
We could be waiting several months for releases from the basket trial or Merck and with summer doldrums close, we could continue on our present path.
Anyone have any more encouraging short term events?
GLTA

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities